ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,384,844, issued on Aug. 12, was assigned to Genentech Inc. (South San Francisco, Calif.).
"Agonists of TREM2" was invented by Ainhoa Echeverria Larraza (South San Francisco, Calif.), David Verne Hansen (Mapleton, Utah), Isidro Hotzel (Brisbane, Calif.), Yi-Chun Hsiao (San Mateo, Calif.), Zhonghua Lin (San Francisco), Dhaya Seshasayee (Cupertino, Calif.) and Benny Chih (Millbrae, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "This application discloses, inter alia, certain antibodies that specifically bind to human TREM2 (triggering receptor expressed on myeloid cells 2). In some embodiments, the antibodies act as TREM2 agonists. In some embodimen...